These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34031314)

  • 1. Juvenile Batten disease: A diagnostic conundrum.
    Niederer K
    JAAPA; 2021 Jun; 34(6):44-47. PubMed ID: 34031314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BATTEN DISEASE CAUSED BY A NOVEL MUTATION IN THE PPT1 GENE.
    Metelitsina TI; Waggoner DJ; Grassi MA
    Retin Cases Brief Rep; 2016; 10(3):211-3. PubMed ID: 26510000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Juvenile neuronal ceroid lipofuscinosis. Ophthalmologic findings and differential diagnosis].
    Krohne TU; Herrmann P; Kopitz J; Rüther K; Holz FG
    Ophthalmologe; 2010 Jul; 107(7):606-11. PubMed ID: 20454901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier detection of Batten disease (juvenile neuronal ceroid-lipofuscinosis).
    Taschner PE; de Vos N; Post JG; Meijers-Heijboer EJ; Hofman I; Loonen MC; Pinckers AJ; Bleeker-Wagemakers EM; Gardiner RM; Breuning MH
    Am J Med Genet; 1995 Jun; 57(2):333-7. PubMed ID: 7668358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal ceroid lipofuscinoses.
    Chabrol B; Caillaud C; Minassian B
    Handb Clin Neurol; 2013; 113():1701-6. PubMed ID: 23622391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.
    de Blieck EA; Augustine EF; Marshall FJ; Adams H; Cialone J; Dure L; Kwon JM; Newhouse N; Rose K; Rothberg PG; Vierhile A; Mink JW;
    Contemp Clin Trials; 2013 Jul; 35(2):48-54. PubMed ID: 23628560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16.
    Gardiner M; Sandford A; Deadman M; Poulton J; Cookson W; Reeders S; Jokiaho I; Peltonen L; Eiberg H; Julier C
    Genomics; 1990 Oct; 8(2):387-90. PubMed ID: 2249854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceroid lipofuscinosis, neuronal 3, Juvenile-Batten disease: case report and literature review.
    Wilkinson ME
    Optometry; 2001 Nov; 72(11):724-8. PubMed ID: 12363260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of neuronal ceroid lipofuscinosis.
    Mole SE; Gardiner M
    Int J Neurol; 1991-1992; 25-26():52-9. PubMed ID: 11980063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Batten disease: clinical aspects, molecular mechanisms, translational science, and future directions.
    Dolisca SB; Mehta M; Pearce DA; Mink JW; Maria BL
    J Child Neurol; 2013 Sep; 28(9):1074-100. PubMed ID: 23838031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid diagnostic test for the major mutation underlying Batten disease.
    Järvelä I; Mitchison HM; Munroe PB; O'Rawe AM; Mole SE; Syvänen AC
    J Med Genet; 1996 Dec; 33(12):1041-2. PubMed ID: 9004140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium.
    Cell; 1995 Sep; 82(6):949-57. PubMed ID: 7553855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease): A Pilot Study of Feasibility and Reliability.
    Ragbeer SN; Augustine EF; Mink JW; Thatcher AR; Vierhile AE; Adams HR
    J Child Neurol; 2016 Mar; 31(4):481-7. PubMed ID: 26336202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.
    Bozorg S; Ramirez-Montealegre D; Chung M; Pearce DA
    Surv Ophthalmol; 2009; 54(4):463-71. PubMed ID: 19539834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of the major deletion in the Batten disease gene CLN3 by allele specific PCR.
    Taschner PE; de Vos N; Breuning MH
    J Med Genet; 1997 Nov; 34(11):955-6. PubMed ID: 9391897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
    de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
    J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal Ceroid Lipofuscinosis Type 6 (CLN6) clinical findings and molecular diagnosis: Costa Rica's experience.
    Badilla-Porras R; Echeverri-McCandless A; Weimer JM; Ulate-Campos A; Soto-Rodríguez A; Gutiérrez-Mata A; Hernández-Con L; Bogantes-Ledezma S; Balmaceda-Meza A; Brudvig J; Sanabria-Castro A
    Orphanet J Rare Dis; 2022 Jan; 17(1):13. PubMed ID: 35012600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease).
    Mitchison HM; Mole SE
    Curr Opin Neurol; 2001 Dec; 14(6):795-803. PubMed ID: 11723391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.